After-Hours Stock Movers
(HPE)
Hewlett Packard Enterprise skyrocketed 35% after hours, building on a 9% intraday gain, after posting a massive Q2 beat with an EPS of $0.79 and revenue of $10.7 billion. The stock’s surge was further fueled by significantly raised Q3 and full-year fiscal 2026 guidance, easily clearing Wall Street expectations across the board.
(CRDO)
Credo Technology Group Holding slid 12% in extended trading despite reporting a Q4 EPS of $1.16 and revenue of $437 million that both topped analysts’ estimates. The post-earnings drop came even as the connectivity solutions provider issued Q1 2027 revenue guidance of $465 million to $475 million, narrowly edging past the consensus forecast.
(FULC)
Fulcrum Therapeutics plunged 30% after announcing it will discontinue its pociredir program for sickle cell disease following FDA feedback regarding potential malignancy risks. In response to the regulatory setback, the biopharmaceutical company has launched a strategic review to explore alternatives, including a potential merger or acquisition.
(ABVX)
Abivax shares rallied 20% on Monday following positive Phase 3 results for its ulcerative colitis drug, obefazimod, which successfully met its primary and all key secondary endpoints. Both once-daily doses achieved clinical remission rates of over 50% at Week 44, significantly outperforming the placebo group in the ABTECT maintenance trial.
(MCHP)
Microchip Technology rose 6% after highlighting strong momentum in its Data Center Solutions Business Unit, which saw revenue increase 62.9% in the March 2026 quarter. The company announced the unit generated $302.7 million in calendar year 2025 and expects approximately 65% growth to reach roughly $500 million in calendar year 2026.
